Breaking News, Promotions & Moves

Arranta Bio Invests $100M in Microbiome Capacity

Also makes key leadership additions of chief operations officer and SVP of business development

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Arranta Bio, a microbiome contract development and manufacturing organization (CDMO), has unveiled plans to invest $100 million to build end-to-end capacity as the first dedicated microbiome CDMO.   At the same time, the company has strengthened its senior leadership team with the addition of David Stevens as chief operations officer and Jason Rahal as senior vice president of business development.   David Stevens Jason Rahal As chief operations officer, Mr. Stevens will be responsible f...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters